Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Companies / Pfizer recalls Citalopram tablets from US market
BackBack

Pfizer recalls Citalopram tablets from US market

Pfizer recalls Citalopram tablets from US market

Premium

Hyderabad: Pfizer recalled Citalopram tablets, manufactured by city-based Aurobindo Pharma, from the US market owing to wrong labelling, the pharma major has said in a filing with the US health regulator.

The latest recall, which was notified by the US FDA on 17 August, involved 720 units of Citalopram tablets, USP, 10 mg, 100-count bottles.

“Label Mix-Up; Bottles of finasteride 5 mg tablets (90-count) have been found to be incorrectly labelled as citalopram 10 mg (100-count) tablets. The lot number, FI0510058-A, appears on both the citalopram 10 mg labels and the finasteride 5 mg labels," the US FDA said while stating the reason for recall.

Earlier, the US FDA had imposed an import alert on the drugs manufactured at Unit-III and VI of the Aurobindo Pharma’ plant in Hyderabad, for inadequate labeling system and for not meeting certain prescribed standards.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 23 Aug 2011, 07:29 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App

Chat with MintGenie